University of Washington School of Medicine, Seattle, WA, USA.
J Neuroimmunol. 2013 Oct 15;263(1-2):28-34. doi: 10.1016/j.jneuroim.2013.07.014. Epub 2013 Jul 29.
Animals that have myelin basic protein (MBP) specific lymphocytes with a Th1(+) phenotype have worse stroke outcome than those that do not. Whether these MBP specific cells contribute to worsened outcome or are merely a consequence of worse outcome is unclear. In these experiments, lymphocytes were obtained from donor animals one month after stroke and transferred to naïve recipient animals at the time of cerebral ischemia. The MBP specific phenotype of donor cells was determined prior to transfer. Animals that received either MBP specific Th1(+) or Th17(+) cells experienced worse neurological outcome, and the degree of impairment correlated with the robustness of MBP specific Th1(+) and Th17(+) responses. These data demonstrate that the immunologic phenotype of antigen specific lymphocytes influences stroke outcome.
具有髓鞘碱性蛋白 (MBP) 特异性淋巴细胞的 Th1(+)表型的动物比不具有该表型的动物的中风预后更差。这些 MBP 特异性细胞是否导致预后恶化,或者仅仅是预后恶化的结果尚不清楚。在这些实验中,中风后一个月从供体动物中获得淋巴细胞,并在脑缺血时转移到幼稚的受体动物。转移前确定供体细胞的 MBP 特异性表型。接受 MBP 特异性 Th1(+)或 Th17(+)细胞的动物经历了更差的神经学结局,并且损伤程度与 MBP 特异性 Th1(+)和 Th17(+)反应的稳健性相关。这些数据表明,抗原特异性淋巴细胞的免疫表型影响中风结局。